ENDEAVOR

Striving to improve the quality of life of Barrett’s Esophagus patients.

Find out more about our research
For Patients
For Researchers
Endeavor-784x624-01

Welcome

WHAT is the ENDEAVOR research project?

ENDEAVOR is an EU-funded research project of 5 years carried out by a consortium of 15 academic partners, 2 general hospitals and 2 industrial partners. It aims to implement an innovative risk stratification method: we want to better determine which Barrett’s esophagus (BE) patients are at risk to develop more invasive cancer and may poorly respond to endoscopic therapy. Like that, we will be able to direct the best treatment and select the most optimal subsequent surveillance program for each patient.

Read more
Endeavor-784x624-01

Welcome

WHAT is the ENDEAVOR research project?

ENDEAVOR is an EU-funded research project of 5 years carried out by a consortium of 15 academic partners, 2 general hospitals and 2 industrial partners. It aims to implement an innovative risk stratification method: we want to better determine which Barrett’s esophagus (BE) patients are at risk to develop more invasive cancer and may poorly respond to endoscopic therapy. Like that, we will be able to direct the best treatment and select the most optimal subsequent surveillance program for each patient.

Read more

Funded by the European Union

The Endeavor research project has received funding from the European Union’s Horizon EU research and innovation programme under grant agreement number: 101136935*.

* Disclaimer: “Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.”

Depositphotos_685111902_S-784

Endeavor EU Follow

ENDEAVOR is an EU-funded research project aiming to improve the quality of life and care of patients with Barrett's Esophagus in Europe #EUfunded #HorizonEU

EndeavorEU
endeavoreu Endeavor EU @endeavoreu ·
21 Oct

Curious about why and how the Endeavor project started?

👀Watch the #ISDE interview with our Chief Investigator Prof. Dr. Sheila Krishnadath to find out more: http://isde-video.net

Reply on Twitter 1848248538431369404 Retweet on Twitter 1848248538431369404 Like on Twitter 1848248538431369404 Twitter 1848248538431369404
endeavoreu Endeavor EU @endeavoreu ·
7 Oct

💥NEWS: the Endeavor #website is now officially live! Find out more about the project on http://endeavoreu.com

❓ Any questions? Let us know!

#EndeavorEU #EUmissiononcancer #HorizonEU

Reply on Twitter 1843253325292265567 Retweet on Twitter 1843253325292265567 Like on Twitter 1843253325292265567 Twitter 1843253325292265567
endeavoreu Endeavor EU @endeavoreu ·
5 Sep

Currently in the process of making #EndeavorEU as patient-friendly as possible by collaborating with our Endeavor #PPI panel 🤝. Engaging patients from the start of the study is essential to make patient-centered improvements to #Healthcare

#EUmissiononcancer #HorizonEU

Reply on Twitter 1831617879122280828 Retweet on Twitter 1831617879122280828 Like on Twitter 1831617879122280828 Twitter 1831617879122280828
endeavoreu Endeavor EU @endeavoreu ·
7 Aug

We are thrilled to announce that the #pilotstudy of our #EndeavorEU trial now has an #NCT number: NCT06523374.
Another step closer to the start of our project! 💥🔎

Find out more at http://clinicaltrials.gov

Reply on Twitter 1821061620140830999 Retweet on Twitter 1821061620140830999 Like on Twitter 1821061620140830999 Twitter 1821061620140830999
Load More